---
title: General_overview_of_H.Pylori_resistance
layout: default
---

# General Overview of H. pylori Resistance

---

## Section 1: Dialogue Prompt
```
Task: Analyze H. pylori resistance by country from the project file
Source: Clinical Laboratory Analysis - 2023 - Lin - Antibiotic resistance in 
       Helicobacter pylori From potential biomolecular-1.pdf
Requirements: 
- Get resistance analysis by country
- Calculate mean, mode, median where possible
```

---

## Section 2: References
```
Publication: Yifan_Lin-Yongfu_Shao (2023)
Link: https://onlinelibrary.wiley.com/doi/10.1002/jcla.24885
```

---

## Section 3: Generated Output

### 1. Amoxicillin Resistance Data
| Region/Country     | Resistance (%) |
|-------------------|----------------|
| Africa (overall)  | 72.6          |
| Algeria           | 0.0           |
| Cameroon          | 100.0         |
| China             | 2.8           |
| Vietnam           | 25.7          |
| Europe (overall)  | 0.4           |
| Spain             | 0.0           |
| Italy             | 1.0           |

*Statistical Analysis: Insufficient consistent data for calculations*

### 2. Clarithromycin Resistance Data
| Region                  | Resistance (%) |
|------------------------|----------------|
| Africa                 | 29.2          |
| Americas               | 10.0          |
| Eastern Mediterranean  | 33.0          |
| Europe                 | 18.0          |
| Southeast Asia         | 10.0          |
| Western Pacific        | 34.0          |

**Statistical Summary:**
```
Mean: 22.37%
Median: 23.5%
Mode: 10% (occurs twice)
```

### 3. Levofloxacin Resistance Data
| Region/Country | Resistance (%) |
|---------------|----------------|
| Asia          | 18.0          |
| China         | 30.3          |
| Indonesia     | 31.0          |
| India         | 54.9          |
| Pakistan      | 15.2          |
| Thailand      | 13.5          |
| Japan         | 36.0          |
| Europe        | 20.0          |
| France        | 17.6          |
| Germany       | 13.4          |
| Spain         | 38.7          |
| Americas      | 14.0          |
| Brazil        | 11.1          |
| USA           | 37.6          |
| Africa        | 17.4          |
| Congo         | 58.8          |
| Nigeria       | 0.0           |

**Statistical Summary:**
```
Mean: 26.68%
Median: 18.0%
Mode: No clear mode
```

### 4. Metronidazole Resistance Data
| Region/Country          | Resistance (%) |
|------------------------|----------------|
| Americas               | 23.0          |
| Bangladesh             | 94.6          |
| China                  | 87.8          |
| India                  | 81.6          |
| Japan                  | 48.0          |
| South Korea            | 27.1          |
| Thailand               | 14.3          |
| Vietnam                | 49.4          |
| Europe                 | 32.0          |
| France                 | 58.6          |
| Austria                | 10.2          |
| New Zealand/Australia  | 50.0          |

**Statistical Summary:**
```
Mean: 48.05%
Median: 48.7%
Mode: No clear mode
```

### 5. Tetracycline Resistance Data
| Region/Country          | Resistance (%) |
|------------------------|----------------|
| China                  | 1.2           |
| Bhutan                 | 0.6           |
| Iran                   | 8.0           |
| India                  | 5.3           |
| Japan                  | 2.0           |
| Europe                 | <1.0          |
| Germany                | 2.5           |
| Spain                  | 0.0           |
| USA                    | 0.87          |
| New Zealand/Australia  | 0.5           |

**Statistical Summary:**
```
Mean: 2.33% (excluding "<1%" for Europe)
Median: 1.2%
Mode: No clear mode
```

---

## Section 4: Expected Output
[To be defined]